Orlistat Sandoz (Orlistat)

Orlistat inhibits gastric and pancreatic lipases, the enzymes responsible for breaking down dietary triglycerides. By blocking these enzymes, about 30 % of the fat from a meal is not hydrolyzed and therefore cannot be absorbed, leading to increased fat excretion in the stool and a reduction in caloric intake.

The prescribed dose of Orlistat Sandoz is determined by the treating physician based on the patient’s clinical condition, body weight and response to therapy. Typically, the medication is taken orally with each main meal that contains fat, but the exact regimen should follow the prescriber’s instructions.

Orlistat Sandoz is generally not recommended for use during pregnancy or while breastfeeding unless the potential benefit outweighs the possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or nursing should discuss alternative weight‑management strategies with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity of Orlistat Sandoz. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After the enquiry, the sales team will request trade or institutional credentials, then provide pricing, availability, shipping details and any necessary import documentation.

Unlike appetite‑suppressing agents, Orlistat works locally in the gastrointestinal tract to reduce fat absorption, which means it does not affect the central nervous system. This mechanism results in a distinct side‑effect profile, primarily gastrointestinal, and it does not carry the cardiovascular or psychiatric risks associated with some other anti‑obesity drugs.

Orlistat Sandoz tablets should be stored at room temperature, below 25 °C, in the original blister pack or container. Keep the product away from moisture, direct sunlight and heat sources to maintain stability and potency throughout its shelf life.

Orlistat Sandoz is taken orally with a meal that contains dietary fat, typically three times daily. The tablets should be swallowed whole with water; they should not be crushed, chewed, or taken on an empty stomach, as the drug’s effect depends on the presence of fat in the gastrointestinal tract.

The most serious risks include rare cases of severe liver injury, acute pancreatitis and significant fat‑soluble vitamin deficiencies, which can lead to complications such as coagulopathy or bone health issues. Patients should be monitored for signs of hepatic dysfunction, abdominal pain, or unexplained bruising, and vitamin supplementation is advised.

Orlistat Sandoz should not be used by individuals with chronic malabsorption syndromes, cholestasis, or those who are allergic to Orlistat or any of the tablet’s excipients. It is also contraindicated in pregnant or breastfeeding women unless a physician determines that the benefits outweigh the risks.